# US 2017/0362642 A1 · Detection of target nucleic acids in a cellular sample

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0362642 A1
- Document ID: US20170362642A1
- Status: Published application
- Kind: A1
- Application number: 15/691,580
- Filed: 2017-08-30
- Published: 2017-12-21
- Earliest claimed: 2012-10-04
- Assignees: The Board of Trustees of the Leland Stanford Junior University
- Applicants: The Board of Trustees of the Leland Stanford Junior University
- Inventors: Garry P. Nolan; Yury Goltsev; Quan Nguyen; Yunqing Ma; Chunfai Lai
- Web page: https://patentgrep.com/patent/US20170362642A1

## CPC

- C12Q 1/6813: Hybridisation assays
- C12Q 1/6841: In situ hybridisation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods of assaying cells of a cellular sample for the presence of a target nucleic acid are provided. Aspects of the methods include evaluating a cellular sample that has been contacted with a nuclease inhibitor for the presence of a target nucleic acid. Also provided are devices and kits that find use in practicing the methods described herein.

## Claims

### Claim at position 1

1-79. (canceled)

### Claim 80

A method of assaying a cellular sample that comprises one or more cells in suspension for the presence of a target nucleic acid, the method comprising:
contacting the cellular sample with, in order: (i) a fixation reagent, (ii) a permeabilization reagent, (iii) an aqueous fixative, and (iv) a nucleic acid detection agent comprising a signal producing system, to produce a suspended hydrated/fixed detection agent-contacted cellular sample; and
measuring a signal produced by the signal producing system to evaluate the suspended hydrated/fixed detection agent-contacted cellular sample for the presence of the target nucleic acid.

### Claim 81 (depends on 80)

The method according to claim 80, wherein the target nucleic acid is a ribonucleic acid (RNA).

### Claim 82 (depends on 81)

The method according to claim 81, wherein the RNA is a microRNA, a fusion gene transcript, or a splice variant.

### Claim 83 (depends on 80)

The method according to claim 80, wherein the method further comprises contacting the cellular sample with a protein detection reagent.

### Claim 84 (depends on 83)

The method according to claim 83, wherein the protein detection reagent comprises a labeled binding member that specifically binds to a target protein.

### Claim 85 (depends on 84)

The method according to claim 84, wherein the labeled binding member comprises an antibody or binding fragment thereof.

### Claim 86 (depends on 85)

The method according to claim 85, wherein the label is a metal.

### Claim 87 (depends on 85)

The method according to claim 85, wherein the measuring comprises measuring the amount of label using mass cytometry.

### Claim 88 (depends on 80)

The method according to claim 80, wherein the signal producing system comprises a nucleic acid probe comprising a label that produces the signal.

### Claim 89 (depends on 88)

The method according to claim 88, wherein the label is a metal.

### Claim 90 (depends on 89)

The method according to claim 89, wherein the measuring comprises mass cytometry.

### Claim 91 (depends on 80)

The method according to claim 80, wherein the signal producing system comprises a signal amplification component.

### Claim 92 (depends on 91)

The method according to claim 91, wherein the signal producing system comprises a branched nucleic acid.

### Claim 93 (depends on 80)

The method according to claim 80, wherein the measuring comprises flow cytometry.

### Claim 94 (depends on 80)

The method according to claim 80, wherein the method comprises, after contacting the cellular sample with the aqueous fixative, storing the cellular sample for a period of time prior to the measuring step.

### Claim 95 (depends on 94)

The method according to claim 94, wherein the storing is in an aqueous buffer comprising a nuclease inhibitor.

### Claim 96 (depends on 95)

The method according to claim 95, wherein the storing is at a temperature below 0° C.

### Claim 97 (depends on 80)

The method according to claim 80, comprising contacting the cellular sample with a stimulating agent prior to contact with the fixation reagent.

### Claim 98 (depends on 80)

The method according to claim 80, wherein the method further comprises obtaining the cellular sample.

### Claim 99 (depends on 80)

The method according to claim 80, wherein the cellular sample is a human cellular sample.

### Claim 100 (depends on 99)

The method according to claim 99, wherein the method further comprises employing a result of the evaluating step to diagnose a state of the human.

### Claim 101 (depends on 99)

The method according to claim 99, wherein the state is a disease state.

### Claim 102 (depends on 101)

The method according to claim 101, wherein the disease state is a cellular proliferative disease state.

### Claim 103 (depends on 80)

The method according to claim 80, further comprising contacting the cellular sample with a nuclease inhibitor after step (iii).

### Claim 104 (depends on 80)

The method according to claim 80, wherein the permeabilization reagent comprises methanol.

### Claim 105 (depends on 80)

The method according to claim 80, wherein the aqueous fixative comprises an aldehyde fixative.

### Claim 106 (depends on 80)

The method according to claim 80, wherein the aqueous fixative comprises at least one of: formaldehyde and glutaraldehyde

### Claim 107

A method comprising:
contacting a cellular sample that comprises one or more cells in suspension with, in order: (i) a fixation reagent, (ii) a permeabilization reagent, and (iii) an aqueous fixative,
to produce a hydrated/fixed suspended cellular sample.

### Claim 108 (depends on 107)

The method according to claim 107, wherein the method further comprises contacting the cellular sample with a protein detection reagent.

### Claim 109 (depends on 108)

The method according to claim 108, wherein the protein detection reagent comprises a labeled binding member that specifically binds to a target protein.

### Claim 110 (depends on 109)

The method according to claim 109, wherein the labeled binding member comprises an antibody or binding fragment thereof.

### Claim 111 (depends on 107)

The method according to claim 107, wherein the method further comprises contacting the cellular sample with a stimulating agent.

### Claim 112 (depends on 107)

The method according to claim 107, wherein the cellular sample is a human cellular sample.

### Claim 113 (depends on 107)

The method according to claim 107, further comprising contacting the cellular sample with a nuclease inhibitor after step (iii).

### Claim 114 (depends on 107)

The method according to claim 107, wherein the permeabilization reagent comprises methanol.

### Claim 115 (depends on 107)

The method according to claim 107, wherein the aqueous fixative comprises an aldehyde fixative.

### Claim 116 (depends on 107)

The method according to claim 107, wherein the aqueous fixative comprises at least one of: formaldehyde and glutaraldehyde.

### Claim 117 (depends on 107)

The method according to claim 107, wherein the permeabilization reagent comprises methanol.

### Claim 118

A method of assaying a cellular sample that comprises one or more cells in suspension for the presence of a target nucleic acid, the method comprising:
contacting the cellular sample with, in order: (i) a first aqueous fixative, (ii) a permeabilization reagent, (iii) a second aqueous fixative, and (iv) a nucleic acid detection agent comprising a signal producing system that comprises a branched nucleic acid, to produce a suspended hydrated/fixed detection agent-contacted cellular sample; and
measuring a signal produced by the signal producing system to evaluate the suspended hydrated/fixed detection agent-contacted cellular sample for the presence of the target RNA, wherein the measuring comprises flow cytometry.

### Claim 119 (depends on 118)

The method according to claim 118, wherein the first and/or second aqueous fixative comprises an aldehyde fixative.

### Claim 120 (depends on 118)

The method according to claim 118, wherein the first and/or second aqueous fixative comprises at least one of: formaldehyde and glutaraldehyde.

### Claim 121 (depends on 118)

The method according to claim 118, further comprising contacting the cellular sample with a nuclease inhibitor after step (iii).

### Claim 122 (depends on 118)

The method according to claim 118, wherein the permeabilization reagent comprises methanol.
